Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 7;3(30):eaau4292.
doi: 10.1126/sciimmunol.aau4292.

Direct reprogramming of fibroblasts into antigen-presenting dendritic cells

Affiliations

Direct reprogramming of fibroblasts into antigen-presenting dendritic cells

Fábio F Rosa et al. Sci Immunol. .

Abstract

Ectopic expression of transcription factors has been used to reprogram differentiated somatic cells toward pluripotency or to directly reprogram them to other somatic cell lineages. This concept has been explored in the context of regenerative medicine. Here, we set out to generate dendritic cells (DCs) capable of presenting antigens from mouse and human fibroblasts. By screening combinations of 18 transcription factors that are expressed in DCs, we have identified PU.1, IRF8, and BATF3 transcription factors as being sufficient to reprogram both mouse and human fibroblasts to induced DCs (iDCs). iDCs acquire a conventional DC type 1-like transcriptional program, with features of interferon-induced maturation. iDCs secrete inflammatory cytokines and have the ability to engulf, process, and present antigens to T cells. Furthermore, we demonstrate that murine iDCs generated here were able to cross-present antigens to CD8+ T cells. Our reprogramming system should facilitate better understanding of DC specification programs and serve as a platform for the development of patient-specific DCs for immunotherapy.

PubMed Disclaimer

Comment in

  • Good things come in threes.
    Yona S, Mildner A. Yona S, et al. Sci Immunol. 2018 Dec 7;3(30):eaav5545. doi: 10.1126/sciimmunol.aav5545. Sci Immunol. 2018. PMID: 30530728

Publication types